News & Media / Media Kit / Downloads
Media Kit / Downloads
Fact Sheets
Fc Optimization Platform
(.PDF, 231.26 Kb)
Dual-Affinity Re-Targeting (DART) Platform Overview
(.PDF, 1.03 Mb)
Cancer Stem Cell Platform Overview,
(.PDF, 1.22 Mb)
Corporate Fact Sheet,
(.PDF, 1.22 Mb)
Corporate Logo
MacroGenics Logo (vector)
(.EPS, 996.84 Kb)
MacroGenics Logo (bitmap),
(.JPG, 135.84 Kb)
MGAH22: HER2+ Tumors (Breast, other)
Phase 1 clinical study in patients with HER2 positive solid tumors.Learn more: MGAH22
Learn more: ClinicalTrials.gov
